Logo image
beta-blockers augment L-type Ca2+ channel activity by targeting spatially restricted beta(2)AR signaling in neurons
Journal article   Open access   Peer reviewed

beta-blockers augment L-type Ca2+ channel activity by targeting spatially restricted beta(2)AR signaling in neurons

Ao Shen, Dana Chen, Mampreet Kaur, Peter Bartels, Bing Xu, Qian Shi, Joseph M. Martinez, Kwun-nok Mimi Man, Madeline Nieves-Cintron, Johannes W. Hell, …
eLife, Vol.8, e49464
10/14/2019
DOI: 10.7554/eLife.49464
PMCID: PMC6813027
PMID: 31609201
url
https://europepmc.org/articles/pmc6813027View
Published (Version of record) Open Access

Abstract

G protein-coupled receptors (GPCRs) transduce pleiotropic intracellular signals in mammalian cells. Here, we report neuronal excitability of beta-blockers carvedilol and alprenolol at clinically relevant nanomolar concentrations. Carvedilol and alprenolol activate beta(2)AR, which promote G protein signaling and cAMP/PKA activities without action of G protein receptor kinases (GRKs). The cAMP/PKA activities are restricted within the immediate vicinity of activated beta(2)AR, leading to selectively enhance PKA-dependent phosphorylation and stimulation of endogenous L-type calcium channel (LTCC) but not AMPA receptor in rat hippocampal neurons. Moreover, we have engineered a mutant beta(2)AR that lacks the catecholamine binding pocket. This mutant is preferentially activated by carvedilol but not the orthosteric agonist isoproterenol. Carvedilol activates the mutant beta(2)AR in mouse hippocampal neurons augmenting LTCC activity through cAMP/PKA signaling. Together, our study identifies a mechanism by which beta-blocker-dependent activation of GPCRs promotes spatially restricted cAMP/PKA signaling to selectively target membrane downstream effectors such as LTCC in neurons.
Biology Life Sciences & Biomedicine Life Sciences & Biomedicine - Other Topics Science & Technology

Details

Metrics

Logo image